UndernutritionNCT07451951
Effectiveness of Small-Quantity vs Medium-Quantity Lipid-Based Nutrient Supplements for Prevention of Undernutrition in Young Children
A study testing Medium-quantity lipid-based nutrient supplement (MQ-LNS) and Small-quantity lipid-based nutrient supplement (SQ-LNS) in people with Undernutrition, run by Aga Khan University at 2 sites in Pakistan.
Trial summary
Nutrition is essential for a child's growth, brain development, and protection from disease. While breastmilk provides the best nutrition for young infants, children older than six months may not get all the nutrients they need from breastmilk and regular foods alone. Read more about this study
- Who is it for?
- Ages 26 to 33 weeksHealthy volunteers can take part
- Conditions the study is for
- Undernutrition
- What is being tested?
- Medium-quantity lipid-based nutrient supplement (MQ-LNS) and Small-quantity lipid-based nutrient supplement (SQ-LNS)
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 1,568 participants
- Where
- 2 sitesPakistan
- Study dates
- 26 Feb 2026to 31 Dec 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 26 to 33 weeks
- All sexes
- Healthy volunteers accepted
- Child
Who may be able to join
- Children aged 6 months (26 weeks) to 7 months and 15 days (33 weeks) with weight-for-length z-score (WLZ) ≥ -2 standard deviation (SD) and mid-upper arm circumference (MUAC) ≥125 mm, born to mothers who are beneficiaries of the Benazir Income Support Programme and registered with the Benazir Nashonuma Programme (BNP) at any point during their pregnancy.
- Permanent residents of the selected districts, with no plan to relocate or migrate within the next 6 months.
- Written informed consent provided by the child's caregivers.
Who cannot join
- Children with moderate acute malnutrition (MAM), defined as WLZ ≥ -3 to < -2 SD, or MUAC ≥115 mm to <125 mm.
- Children with severe acute malnutrition (SAM), defined as WLZ < -3 SD or MUAC <115 mm or presence of bilateral pitting edema, who require therapeutic feeding.
- Children with known congenital anomalies, chronic illness, or conditions affecting growth or feeding (for example, cerebral palsy or congenital heart disease).
- Children already enrolled in any nutritional supplementation other than BNP or another clinical trial.
- Children whose families will be unwilling to provide informed consent, or likely to be unavailable for follow-up.
Trial locations and contacts
2 sites in 1 country. Contact the study team or a site near you to ask about taking part.
Pakistan2 sites, 2 recruiting
- Recruiting
BNP Facilitation Centers
Dadu, Sindh
Dr Sajid Soofi, +922134864798, sajid.soofi@aku.edu
- Recruiting
BNP Facilitation Centers
Peshawar, Khyber Pakhtunkhwa
Dr Sajid Soofi, +922134864798, sajid.soofi@aku.edu
About this study
Official title: Effectiveness of Small-Quantity vs Medium-Quantity Lipid-Based Nutrient Supplements for Prevention of Undernutrition in Young Children: An Individually Randomized, Parallel-Group, Non-Inferiority Trial
Nutrition is essential for a child's growth, brain development, and protection from disease. While breastmilk provides the best nutrition for young infants, children older than six months may not get all the nutrients they need from breastmilk and regular foods alone. For this reason, some children receive special nutrient supplements to support healthy growth.
Lipid-based nutrient supplements (LNS) are one type of supplement that provides important vitamins and minerals. These supplements are used in many countries to help prevent undernutrition in young children. In Pakistan, the government-led multisectoral nutrition program under the social safety net program currently provides medium-quantity LNS to children starting at six months of age. However, it is not known whether a smaller-quantity LNS could provide similar benefits for children in this age group from under-resourced communities that have limited access to nutritious foods.
Read more
The goal of this trial is to learn whether small-quantity lipid-based nutrient supplements (SQ-LNS) work as well as medium-quantity lipid-based nutrient supplements (MQ-LNS) in preventing undernutrition in children aged 6 to 12 months.
The main questions this study aims to answer are:
- Does SQ-LNS work as well as MQ-LNS in supporting healthy growth, including reducing stunting, wasting, and underweight?
- Does SQ-LNS work as well as MQ-LNS in reducing anemia?
Researchers will compare SQ-LNS and MQ-LNS to see if SQ-LNS is as good as MQ-LNS in preventing undernutrition.
The study is being conducted in Dadu and Peshawar, Pakistan. Participants will be followed until 12 months of age.
Participants will:
- Receive either SQ-LNS or MQ-LNS once daily until 12 months of age
- Have their length, weight and mid-upper arm circumference (MUAC) measured monthly
- Have their blood screened for anemia at enrollment and at 12 months of age
- Conditions
- Undernutrition
- Being tested
- Medium-quantity lipid-based nutrient supplement (MQ-LNS), Small-quantity lipid-based nutrient supplement (SQ-LNS)
- Keywords
- Stunting, Wasting, Anemia, Underweight, Small-quantity lipid-based nutrient supplement, Child nutrition, Medium-quantity lipid-based nutrient supplement
- Medical subject headings
- Malnutrition, Growth Disorders, Cachexia, Anemia, Thinness
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Medium-quantity lipid-based nutrient supplement (MQ-LNS)Dietary supplement
50 g/day lipid-based nutrient supplement providing energy and essential micronutrients, administered daily for 6 months.
Small-quantity lipid-based nutrient supplement (SQ-LNS)Dietary supplement
20 g/day lipid-based nutrient supplement providing energy and essential micronutrients, administered daily for 6 months.
| Study group | Role | What they receive |
|---|---|---|
| Medium-quantity lipid-based nutrient supplement (MQ-LNS) | Active comparator | Children receiving MQ-LNS Receives: Dietary Supplement: Medium-quantity lipid-based nutrient supplement (MQ-LNS) |
| Small-quantity lipid-based nutrient supplement (SQ-LNS) | Experimental | Children receiving SQ-LNS Receives: Dietary Supplement: Small-quantity lipid-based nutrient supplement (SQ-LNS) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Stunting
length-for-age z-score (LAZ) < -2 SD
Measured: Monthly from enrollment to the end of intervention period at 6 months
Secondary outcomes (4)
Wasting
weight-for-length z-score (WLZ) < -2 SD
Measured: Monthly from enrollment to the end of intervention period at 6 months
Underweight
weight-for-age z-score (WAZ) < -2 SD
Measured: Monthly from enrollment to the end of intervention period at 6 months
Morbidity
Includes diarrhea (liquid stools defined as ≥3 loose or watery stools within 24 hour), respiratory infection (cough plus rapid, difficult breathing), vomiting, fever, rash/sores, coughing, wheezing and pneumonia.
Measured: Monthly from enrollment to the end of intervention period at 6 months
Prevalence of anemia
hemoglobin <10.5 g/dL.
For mild anemia: hemoglobin 9.5 - 10.4 g/dL For moderate anemia: 7.0 - 9.4 g/dL For severe anemia: <7.0 g/dL
Measured: At enrollment and later at the end of intervention period at 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Mar 2026
- Study start26 Feb 2026
- Primary completion31 Jul 2027 (estimated)
- Study completion31 Dec 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (8)Papers the sponsor has linked to this study.
- Other trials for UndernutritionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 1,568 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Aga Khan University
- Sponsor type
- University, hospital or other
- Collaborators
- United Nations World Food Programme (WFP), Benazir Income Support Programme (BISP)
- Responsible party
- Principal investigator, Dr Shabina Ariff, Aga Khan University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07451951
- Sponsor's protocol ID
- 11806
- Other IDs
- 1000001355
- Status last verified
- Sep 2026
- First submitted
- 2 Mar 2026
- Last updated
- 3 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: De-identified individual participant data (IPD) underlying the results reported in publications will be shared.
Publications
Dewey KG, Arnold CD, Wessells KR, Stewart CP. Lipid-based nutrient supplements for prevention of child undernutrition: when less may be more. Am J Clin Nutr. 2023 Dec;118(6):1133-1144. doi: 10.1016/j.ajcnut.2023.09.007. Epub 2023 Sep 23.
PubMed 37742931Prado EL, Arnold CD, Wessells KR, Stewart CP, Abbeddou S, Adu-Afarwuah S, Arnold BF, Ashorn U, Ashorn P, Becquey E, Brown KH, Chandna J, Christian P, Dentz HN, Dulience SJL, Fernald LCH, Galasso E, Hallamaa L, Hess SY, Huybregts L, Iannotti LL, Jimenez EY, Kohl P, Lartey A, Le Port A, Luby SP, Maleta K, Matchado A, Matias SL, Mridha MK, Ntozini R, Null C, Ocansey ME, Parvez SM, Phuka J, Pickering AJ, Prendergast AJ, Shamim AA, Siddiqui Z, Tofail F, Weber AM, Wu LSF, Dewey KG. Small-quantity lipid-based nutrient supplements for children age 6-24 months: a systematic review and individual participant data meta-analysis of effects on developmental outcomes and effect modifiers. Am J Clin Nutr. 2021 Nov 2;114(Suppl 1):43S-67S. doi: 10.1093/ajcn/nqab277.
PubMed 34590116Dewey KG, Stewart CP, Wessells KR, Prado EL, Arnold CD. Small-quantity lipid-based nutrient supplements for the prevention of child malnutrition and promotion of healthy development: overview of individual participant data meta-analysis and programmatic implications. Am J Clin Nutr. 2021 Nov 2;114(Suppl 1):3S-14S. doi: 10.1093/ajcn/nqab279.
PubMed 34590696Stewart CP, Dewey KG, Lin A, Pickering AJ, Byrd KA, Jannat K, Ali S, Rao G, Dentz HN, Kiprotich M, Arnold CD, Arnold BF, Allen LH, Shahab-Ferdows S, Ercumen A, Grembi JA, Naser AM, Rahman M, Unicomb L, Colford JM Jr, Luby SP, Null C. Effects of lipid-based nutrient supplements and infant and young child feeding counseling with or without improved water, sanitation, and hygiene (WASH) on anemia and micronutrient status: results from 2 cluster-randomized trials in Kenya and Bangladesh. Am J Clin Nutr. 2019 Jan 1;109(1):148-164. doi: 10.1093/ajcn/nqy239.
PubMed 30624600Siega-Riz AM, Estrada Del Campo Y, Kinlaw A, Reinhart GA, Allen LH, Shahab-Ferdows S, Heck J, Suchindran CM, Bentley ME. Effect of supplementation with a lipid-based nutrient supplement on the micronutrient status of children aged 6-18 months living in the rural region of Intibuca, Honduras. Paediatr Perinat Epidemiol. 2014 May;28(3):245-54. doi: 10.1111/ppe.12117. Epub 2014 Mar 13.
PubMed 24628577Abbeddou S, Yakes Jimenez E, Some JW, Ouedraogo JB, Brown KH, Hess SY. Small-quantity lipid-based nutrient supplements containing different amounts of zinc along with diarrhea and malaria treatment increase iron and vitamin A status and reduce anemia prevalence, but do not affect zinc status in young Burkinabe children: a cluster-randomized trial. BMC Pediatr. 2017 Feb 2;17(1):46. doi: 10.1186/s12887-016-0765-9.
PubMed 28152989Das JK, Salam RA, Hadi YB, Sadiq Sheikh S, Bhutta AZ, Weise Prinzo Z, Bhutta ZA. Preventive lipid-based nutrient supplements given with complementary foods to infants and young children 6 to 23 months of age for health, nutrition, and developmental outcomes. Cochrane Database Syst Rev. 2019 May 2;5(5):CD012611. doi: 10.1002/14651858.CD012611.pub3.
PubMed 31046132Ariff S, Alam R, Chauhdary IA, Muhammad S, Khan GN, Maznani I, Wali N, Muhammad S, Ghaffar A, Ihtesham Y, Badar A, Raza A, Ijaz A, Rana R, de Pee S, Soofi S, Bhutta ZA. Effectiveness of small-quantity versus medium-quantity lipid-based nutrient supplements for prevention of undernutrition in young children: protocol for an individually randomised, parallel-group, non-inferiority trial. BMJ Open. 2026 Sep 29;16(9):e122865. doi: 10.1136/bmjopen-2026-122865.
PubMed 42810807
Study at a glance
From the registry record, last updated by the sponsor on 3 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effectiveness of Small-Quantity vs Medium-Quantity Lipid-Based Nutrient Supplements for Prevention of Undernutrition in Young Children: An Individually Randomized, Parallel-Group, Non-Inferiority Trial
- ClinicalTrials.gov ID
- NCT07451951
- Acronym / sponsor ID
- 11806
- Conditions
- Undernutrition
- Keywords
- Stunting, Wasting, Anemia, Underweight, Small-quantity lipid-based nutrient supplement, Child nutrition, Medium-quantity lipid-based nutrient supplement
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 1,568 participants (estimated)
- Lead sponsor
- Aga Khan UniversityUniversity, hospital or other
- Collaborators
- United Nations World Food Programme (WFP), Benazir Income Support Programme (BISP)
- Study start
- 26 Feb 2026 (actual)
- Primary completion
- 31 Jul 2027 (estimated)
- Study completion
- 31 Dec 2028 (estimated)
- First posted
- 5 Mar 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Nutrition is essential for a child's growth, brain development, and protection from disease. While breastmilk provides the best nutrition for young infants, children older than six months may not get all the nutrients they need from breastmilk and regular foods alone. For this reason, some children receive special nutrient supplements to support healthy growth.
Lipid-based nutrient supplements (LNS) are one type of supplement that provides important vitamins and minerals. These supplements are used in many countries to help prevent undernutrition in young children. In Pakistan, the government-led multisectoral nutrition program under the social safety net program currently provides medium-quantity LNS to children starting at six months of age. However, it is not known whether a smaller-quantity LNS could provide similar benefits for children in this age group from under-resourced communities that have limited access to nutritious foods.
The goal of this trial is to learn whether small-quantity lipid-based nutrient supplements (SQ-LNS) work as well as medium-quantity lipid-based nutrient supplements (MQ-LNS) in preventing undernutrition in children aged 6 to 12 months.
The main questions this study aims to answer are:
- Does SQ-LNS work as well as MQ-LNS in supporting healthy growth, including reducing stunting, wasting, and underweight?
- Does SQ-LNS work as well as MQ-LNS in reducing anemia?
Researchers will compare SQ-LNS and MQ-LNS to see if SQ-LNS is as good as MQ-LNS in preventing undernutrition.
The study is being conducted in Dadu and Peshawar, Pakistan. Participants will be followed until 12 months of age.
Participants will:
- Receive either SQ-LNS or MQ-LNS once daily until 12 months of age
- Have their length, weight and mid-upper arm circumference (MUAC) measured monthly
- Have their blood screened for anemia at enrollment and at 12 months of age
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Medium-quantity lipid-based nutrient supplement (MQ-LNS) | Active comparator | Dietary Supplement: Medium-quantity lipid-based nutrient supplement (MQ-LNS)Children receiving MQ-LNS |
| Small-quantity lipid-based nutrient supplement (SQ-LNS) | Experimental | Dietary Supplement: Small-quantity lipid-based nutrient supplement (SQ-LNS)Children receiving SQ-LNS |
Who may qualify
- Ages
- 26 to 33 weeks
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child
Key inclusion criteria (3 listed)
- Children aged 6 months (26 weeks) to 7 months and 15 days (33 weeks) with weight-for-length z-score (WLZ) ≥ -2 standard deviation (SD) and mid-upper arm circumference (MUAC) ≥125 mm, born to mothers who are beneficiaries of the Benazir Income Support Programme and registered with the Benazir Nashonuma Programme (BNP) at any point during their pregnancy.
- Permanent residents of the selected districts, with no plan to relocate or migrate within the next 6 months.
- Written informed consent provided by the child's caregivers.
Key exclusion criteria (5 listed)
- Children with moderate acute malnutrition (MAM), defined as WLZ ≥ -3 to < -2 SD, or MUAC ≥115 mm to <125 mm.
- Children with severe acute malnutrition (SAM), defined as WLZ < -3 SD or MUAC <115 mm or presence of bilateral pitting edema, who require therapeutic feeding.
- Children with known congenital anomalies, chronic illness, or conditions affecting growth or feeding (for example, cerebral palsy or congenital heart disease).
- Children already enrolled in any nutritional supplementation other than BNP or another clinical trial.
- Children whose families will be unwilling to provide informed consent, or likely to be unavailable for follow-up.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Medium-quantity lipid-based nutrient supplement (MQ-LNS)50 g/day lipid-based nutrient supplement providing energy and essential micronutrients, administered daily for 6 months. | Dietary supplement | Medium-quantity lipid-based nutrient supplement (MQ-LNS) |
| Small-quantity lipid-based nutrient supplement (SQ-LNS)20 g/day lipid-based nutrient supplement providing energy and essential micronutrients, administered daily for 6 months. | Dietary supplement | Small-quantity lipid-based nutrient supplement (SQ-LNS) |
Primary outcome
Stunting
Time frame: Monthly from enrollment to the end of intervention period at 6 months
length-for-age z-score (LAZ) < -2 SD
4 secondary outcomes
Wasting
Time frame: Monthly from enrollment to the end of intervention period at 6 months
Underweight
Time frame: Monthly from enrollment to the end of intervention period at 6 months
Morbidity
Time frame: Monthly from enrollment to the end of intervention period at 6 months
Prevalence of anemia
Time frame: At enrollment and later at the end of intervention period at 6 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Sep 2026.
- Background: PubMed 37742931Dewey KG, Arnold CD, Wessells KR, Stewart CP. Lipid-based nutrient supplements for prevention of child undernutrition: when less may be more. Am J Clin Nutr. 2023 Dec;118(6):1133-1144. doi: 10.1016/j.ajcnut.2023.09.007. Epub 2023 Sep 23.
- Background: PubMed 34590116Prado EL, Arnold CD, Wessells KR, Stewart CP, Abbeddou S, Adu-Afarwuah S, Arnold BF, Ashorn U, Ashorn P, Becquey E, Brown KH, Chandna J, Christian P, Dentz HN, Dulience SJL, Fernald LCH, Galasso E, Hallamaa L, Hess SY, Huybregts L, Iannotti LL, Jimenez EY, Kohl P, Lartey A, Le Port A, Luby SP, Maleta K, Matchado A, Matias SL, Mridha MK, Ntozini R, Null C, Ocansey ME, Parvez SM, Phuka J, Pickering AJ, Prendergast AJ, Shamim AA, Siddiqui Z, Tofail F, Weber AM, Wu LSF, Dewey KG. Small-quantity lipid-based nutrient supplements for children age 6-24 months: a systematic review and individual participant data meta-analysis of effects on developmental outcomes and effect modifiers. Am J Clin Nutr. 2021 Nov 2;114(Suppl 1):43S-67S. doi: 10.1093/ajcn/nqab277.
- Background: PubMed 34590696Dewey KG, Stewart CP, Wessells KR, Prado EL, Arnold CD. Small-quantity lipid-based nutrient supplements for the prevention of child malnutrition and promotion of healthy development: overview of individual participant data meta-analysis and programmatic implications. Am J Clin Nutr. 2021 Nov 2;114(Suppl 1):3S-14S. doi: 10.1093/ajcn/nqab279.
- Background: PubMed 30624600Stewart CP, Dewey KG, Lin A, Pickering AJ, Byrd KA, Jannat K, Ali S, Rao G, Dentz HN, Kiprotich M, Arnold CD, Arnold BF, Allen LH, Shahab-Ferdows S, Ercumen A, Grembi JA, Naser AM, Rahman M, Unicomb L, Colford JM Jr, Luby SP, Null C. Effects of lipid-based nutrient supplements and infant and young child feeding counseling with or without improved water, sanitation, and hygiene (WASH) on anemia and micronutrient status: results from 2 cluster-randomized trials in Kenya and Bangladesh. Am J Clin Nutr. 2019 Jan 1;109(1):148-164. doi: 10.1093/ajcn/nqy239.
- Background: PubMed 24628577Siega-Riz AM, Estrada Del Campo Y, Kinlaw A, Reinhart GA, Allen LH, Shahab-Ferdows S, Heck J, Suchindran CM, Bentley ME. Effect of supplementation with a lipid-based nutrient supplement on the micronutrient status of children aged 6-18 months living in the rural region of Intibuca, Honduras. Paediatr Perinat Epidemiol. 2014 May;28(3):245-54. doi: 10.1111/ppe.12117. Epub 2014 Mar 13.
- Background: PubMed 28152989Abbeddou S, Yakes Jimenez E, Some JW, Ouedraogo JB, Brown KH, Hess SY. Small-quantity lipid-based nutrient supplements containing different amounts of zinc along with diarrhea and malaria treatment increase iron and vitamin A status and reduce anemia prevalence, but do not affect zinc status in young Burkinabe children: a cluster-randomized trial. BMC Pediatr. 2017 Feb 2;17(1):46. doi: 10.1186/s12887-016-0765-9.
- Background: PubMed 31046132Das JK, Salam RA, Hadi YB, Sadiq Sheikh S, Bhutta AZ, Weise Prinzo Z, Bhutta ZA. Preventive lipid-based nutrient supplements given with complementary foods to infants and young children 6 to 23 months of age for health, nutrition, and developmental outcomes. Cochrane Database Syst Rev. 2019 May 2;5(5):CD012611. doi: 10.1002/14651858.CD012611.pub3.
- Derived from this study: PubMed 42810807Ariff S, Alam R, Chauhdary IA, Muhammad S, Khan GN, Maznani I, Wali N, Muhammad S, Ghaffar A, Ihtesham Y, Badar A, Raza A, Ijaz A, Rana R, de Pee S, Soofi S, Bhutta ZA. Effectiveness of small-quantity versus medium-quantity lipid-based nutrient supplements for prevention of undernutrition in young children: protocol for an individually randomised, parallel-group, non-inferiority trial. BMJ Open. 2026 Sep 29;16(9):e122865. doi: 10.1136/bmjopen-2026-122865.
- Strategies for ensuring adequate nutrientintake for infants and young children duringthe period of complementary feedingLink provided by the sponsor.
- Individual participant dataSharing planned: Yes. De-identified individual participant data (IPD) underlying the results reported in publications will be shared.
Related trials for Undernutrition
Not yet recruiting
Efficacy of MAGNESIO TOTAL on Sleep Quality and Quality of Life in Adults
Sleep Quality, Magnesium Deficiency
RecruitingObservational study
A Natural History Study of Bone and Mineral Disorders
Tumor Induced Osteomalcia, Osteomalacia
Recruiting
Effectiveness of an Alternative Protocol in the Management of Acute Malnutrition
Acute Malnutrition With no Complications
Recruiting
Milk Fat Globule Membrane-Enhanced RUTF for Children With Severe Acute Malnutrition
Severe Acute Malnutrition, Cognitive Impairment
Not yet recruiting
Effects of Increased Water Intake on Hormonal Response, Hydration Status, and Physical Function in Low-drinking Older Adults
Dehydrated, Water-Electrolyte Imbalance, Malnutrition, Dehydration (Physiology)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Medium-quantity lipid-based nutrient supplement (MQ-LNS) and Small-quantity lipid-based nutrient supplement (SQ-LNS) in people with Undernutrition, run by Aga Khan University at 2 sites in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 3 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Stunting (time frame: Monthly from enrollment to the end of intervention period at 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07451951, which also lists 8 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Sep 2026.